Papers

Research literature with structured metadata.

Trials

Registered studies by status, phase, and compound.

Topics

Indications and themes psychedelics are researched for.

Compounds

Evidence across molecules with rich data.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across research, policy, and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

Results

Compare outcome data across trials and publications.

Research Snapshot

One-page overview of trials, participants, papers, and research networks.

Clinical Guidelines

Trial-anchored manuals and protocol guidance with competency mapping.

Research recaps

Monthly evidence summaries with key takeaways.

Map of research

Landscape view of trials, compounds, and outcomes.

Newsletter

Weekly or daily updates on trials, publications, analysis, and more.

Research Groups

Worldwide map of psychedelic research centres by region.

Road to Access

Science, regulation, and economics on the path to patient access.

Research Network

Interactive co-authorship map of psychedelic researchers.

Top papers

Find needles in the haystack of psychedelic research per topic.

AskBeta
Pricing

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.

Compound Leaderboard

Psychedelic compounds ranked by research activity.

1Ketamine
445
2Psilocybin
328
3MDMA
138
4Esketamine
95
5LSD
51
6DMT
28
75-MeO-DMT
16
8Ayahuasca
14
9Ibogaine
8
102C-X
2
11Mescaline
2

11 compounds with clinical trials data

Explore all compounds →

Blossom Research Snapshot

moreblossom.com

Clinical trials, participants, and published papers across all therapeutic topics in psychedelic science.

Topic
Depressive Disorders
595
59,978
1,202
Major Depressive Disorder (MDD)
313
28,681
395
Treatment-Resistant Depression (TRD)
209
20,328
341
Bipolar Disorder
50
6,502
125
Peripartum
17
2,722
7
Premenstrual Dysphoric Disorder (PMDD)00
2
Neuroimaging & Brain Measures
231
12,158
389
Healthy Volunteers
223
12,703
420
PTSD
120
10,215
343
Anxiety Disorders
110
11,871
762
Palliative & End-of-Life Distress
53
2,271
183
Substance Use Disorders (SUD)
108
6,831
566
Alcohol Use Disorder (AUD)
45
3,042
110
Opioid Use Disorder (OUD)
25
1,476
40
Tobacco/Nicotine Use Disorder (TUD)
5
257
63
Suicidality
94
10,988
240
Chronic Pain
78
5,009
173
Headache Disorders (Cluster & Migraine)
15
582
89
Fibromyalgia
11
461
5
Safety & Risk Management
72
3,632
326
Set & Setting
53
2,517
155
Interpersonal Functioning & Social Connectedness
34
1,314
178
Topic
Neurocognitive Disorders
32
2,944
96
Veterans
31
1,268
50
Implementation & Service Delivery
29
2,344
29
Adolescents
19
989
132
Neurological Injury
19
1,370
28
Traumatic Brain Injury (TBI)
12
1,015
12
Eating Disorders
18
461
34
Obsessive-Compulsive Disorder (OCD)
18
1,607
76
Immunology & Inflammation
14
551
101
Older Adults
14
2,204
65
Medicinal Chemistry & Drug Development
13
267
192
Microdosing
13
416
130
Schizophrenia
9
1,501
205
Autism Spectrum Disorder (ASD)
8
216
27
Health Economics & Reimbursement
7
959
26
Personality & Trait Factors
6
1,148
146
Personality Disorders
6
210
19
Borderline Personality Disorder (BPD)
5
198
12
Equity and Ethics
5
167
123
Public Health, Prevention & Behaviour Change
5
484
124
Creativity
4
204
88